Cases of HER-2 FISH positive but IHC negative tumors have been reported in the past, making up about 2% of all breast cancer patients or 10% of HER-2 FISH positive breast tumors (Sauter et al. [2009]; Lipton et al. [2010]). This evidence concerns the gene ERBB2 and breast neoplasm.